RSV showdown: vaccine for moms vs. antibody for newborns – which works better?
NCT ID NCT07251972
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This study compares two methods to prevent RSV, a common virus that can cause serious breathing problems in babies. One method is a vaccine given to pregnant women, which passes protection to the baby before birth. The other is an antibody shot given directly to the newborn. The trial will track about 1,050 full-term newborns to see which approach leads to fewer emergency room visits for bronchiolitis.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for BRONCHIOLITIS are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
Chru Nancy
Nancy, France
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Can a simple decision tool cut time on breathing support for sick infants?
- Could a lower oxygen threshold get kids home sooner?
- Laughing gas may soothe painful tube insertion in toddlers
- Which flow rate helps babies breathe better? new study tests two options
- AI stethoscope aims to cut unnecessary antibiotics in kids with cough
- Ultrasound vs x-ray: a new way to spot lung issues in sick babies?